Close Menu

DNA shearing

NEW YORK (GenomeWeb News) – Pressure BioSciences said in a filing with the US Securities and Exchange Commission today that Cole-Parmer has signed an agreement to distribute the firm's PBI Shredder SG3 System on a non-exclusive basis.

NEW YORK (GenomeWeb News) – Life Technologies will supply Covaris's DNA fragmenting system with its Ion PGM and Ion Proton sequencers, Woburn, Mass.-based Covaris said after the close of the market Wednesday.

Under the deal, BGI will use Covaris' LE220 instrument and consumables as part of its library construction process for next-generation sequencing at several of its laboratories.

The firms will offer a combination of their sample prep technologies for next-generation sequencing workflows.

The firms will co-market Illumina's sequencing instruments with Covaris' sample prep technology.

The agreement covers Agilent's target enrichment and Covaris' DNA shearing technology.

Under the agreement, Agilent will market Covaris' S2 DNA shearing system for use with its SureSelect Target Enrichment System, a solution-based DNA selection method for high-throughput sequencing.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.